<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Revive Therapeutics Provides Update on Phase III Trials
Image Overlay - Revive Therapeutics Provides Update on Phase III Trials

Revive Therapeutics Provides Update on Phase III Trials

Revive Therapeutics Provides Update on Phase III Trials

Revive Therapeutics Ltd., a life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is proceeding with a phase III clinical trial of Bucillamine in patients with mild-moderate COVID-19 following FDA approval. Revive expects trials to take place in up to 10 clinical trial sites across the U.S.; patient screening will begin in Q3. Yourway is headquartered Allentown, Pennsylvania – with a reliable transportation network, we are able to make deliveries across the country (and around the world) within hours, not days.

Back to Index
Media

Upcoming Events

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Global Clinical Trial Innovation, Challenges, and Perspectives

June 6, 2024
Yourway's EU Flagship Depot in Dublin, Ireland

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?